Skip Ribbon Commands
Skip to main content

Stents

DISCOVERY 1TO3 Trial

60 MVD patients with OFDI, single arm, primary endpoint TLF @ 12M. Published

MASTER Trial

500 STEMI patients, randomised 1:3 vs Kaname BMS, primary endpoint TVF 12M. Published and completed

TCD-10023PK Trial

20 patients, single arm, pharmocokinetics. Published.

See all clinical evidence

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.